SCHEMBL18565231

SCHEMBL18565231

c1ccc(N(c2ccccc2)c2ccc3c4ccccc4n(-c4ccc(-c5nc(-c6ccc(-n7c8ccccc8c8ccc(N(c9ccccc9)c9ccccc9)cc87)cc6)nc(-c6ccc(-n7c8ccccc8c8ccc(N(c9ccccc9)c9ccccc9)cc87)cc6)n5)cc4)c3c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
ATM Q13315 1/20 0.44
MAPT P10636 6/20 0.36
CYP3A4 P08684 6/20 0.36
CYP2D6 P10635 6/20 0.36
CYP1A2 P05177 5/20 0.36
CYP2C19 P33261 5/20 0.36
TSHR P16473 5/20 0.36
ALDH1A1 P00352 5/20 0.36
CYP2C9 P11712 4/20 0.36
HPGD P15428 4/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
LMNA P02545 3/20 0.36
GLA P06280 1/20 0.36
RECQL P46063 1/20 0.36
HIF1A Q16665 1/20 0.36
HDAC4 P56524 1/20 0.35
TP53 P04637 4/20 0.34
PTGER4 P35408 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18565242 0.97 KDM4E (0.47) KDM4EL3MBTL1ATMMAPTCYP3A4
SCHEMBL18565226 0.94 KDM4E (0.41) KDM4EL3MBTL1ATMMAPTCYP3A4
SCHEMBL18565219 0.92 KDM4E (0.44) KDM4EL3MBTL1ATMMAPTCYP3A4
SCHEMBL18565237 0.91 KDM4E (0.44) KDM4EL3MBTL1ATMMAPTCYP3A4
SCHEMBL18565249 0.91 KDM4E (0.46) KDM4EL3MBTL1ATMMAPTCYP3A4
SCHEMBL15785783 0.91 KDM4E (0.42) KDM4EL3MBTL1ATMMAPTCYP3A4
SCHEMBL18511441 0.91 KDM4E (0.42) KDM4EL3MBTL1ATMMAPTCYP3A4
SCHEMBL24432758 0.91 KDM4E (0.35) KDM4EL3MBTL1ATMMAPTCYP3A4
SCHEMBL11921999 0.90 L3MBTL1 (0.50) KDM4EL3MBTL1ATMMAPTCYP3A4
SCHEMBL11921978 0.90 L3MBTL1 (0.50) KDM4EL3MBTL1ATMMAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-05-14 US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device EED, BMI1, CD99 KDM4E 225/4885L3MBTL1 1263/4885ATM 3092/4885
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE EED, BMI1, CD99 KDM4E 225/4885L3MBTL1 1263/4885ATM 3092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.